Page 76 - IngresoDr.MtzLanao
P. 76
BIBLIOGRAFIA
Abdulla A, Edwina AE, Flint RB, Allegaert K, Wildschut ED, Koch BCP, de Hoog M (2021). Model-
Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review. Front Pediatr.,
9: 624639.
Abrahamsson B, McAllister M, Augustijns P, Zane P, Butler J, Holm R, Langguth P, Lindahl A,
Müllertz A, Pepin X, Rostami-Hodjegan A, Sjögren E, Berntsson M, Lennernäs H (2020). Six years
of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project. Eur J
Pharm Biopharm., 152: 236-247.
Advanced Manufacturing. FDA. 2020.
Alvarez CI, Concheiro A (2013). Cribado biofarmacéutico en el descubrimiento de fármacos y
estudios de preformulación (Capítulo 17). (Vol I. pp 491-524). J Domenech Berrozpe, J Martínez
Lanao, C Peraire Guitart (Eds). En Tratado general de Biofarmacia y Farmacocinética. Editorial
Síntesis.
An G, Morris ME (2012). A physiologically based pharmacokinetic model of mitoxantrone in mice
and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.
AAPS J., 14(2): 352-364.
Agoram B, Woltosz WS, Bolger MB (2001). Predicting the impact of physiological and
biochemical processes on oral drug bioavailability Adv Drug Deliv Rev. 50 Suppl 1: S41-567.
Agrawal V, Woo JH, Borthakur G, Kantarjian H, Frankel AE (2013). Red blood cell-encapsulated
L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute
myeloid leukemia. Protein Pept Lett., 20(4): 392-402.
Alonso IG, Lanao JM, Domínguez-Gil A (1990). Evolución histórica de la Biofarmacia y
Farmacocinética, una nueva disciplina farmacéutica. Industria farmacéutica: Equipos, procesos
y tecnología., 2: 151-156.
Amidon GL, Lennernäs H, Shah VP, Crison JR (1995). A theoretical basis for a biopharmaceutic
drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
Pharm Res., 12(3): 413-420.
Anton N, Benoit JP, Saulnier P (2008). Design and production of nanoparticles formulated from
nano-emulsion templates-a review. J Control Release., 128(3): 185-199.
Anderluzzi G, Lou G, Su Y, Perrie Y (2019). Scalable Manufacturing Processes for Solid Lipid
Nanoparticles. Pharm Nanotechnol., 7(6): 444-459.
Arden NS, Fisher AC, Tyner K, Yu LX, Lee SL, Kopcha M (2021). Industry 4.0 for pharmaceutical
manufacturing: Preparing for the smart factories of the future. Int J Pharm., 602: 120554.
Arévalo-Pérez R, Maderuelo C, Lanao JM (2020). Recent advances in colon drug delivery systems.
J Control Release., 327: 703-724.
Awad A, Fina F, Trenfield SJ, Patel P, Goyanes A, Gaisford S, et al. (2019). 3D printed pellets
(Miniprintlets): A novel, multi-drug, controlled release platform technology. Pharmaceutics.,
11(4): 148.
74
